logo
Plus   Neg
Share
Email

Becton, Dickinson Acquires Sirigen Group

Becton, Dickinson and Co. (BDX) or BD announced that it has acquired Sirigen Group Limited, a developer of unique polymer dyes that are used in flow cytometry and can be applied to other technologies.

Sirigen's polymer technology is based on Nobel Prize-winning research in conductive plastics and creates the potential for the development of novel dyes that are four to ten times brighter than conventional dyes - a breakthrough in the field.

The financial terms of the acquisition were not disclosed. On a GAAP basis, the transaction is expected to be dilutive to fiscal 2012 earnings per share by approximately $0.01.

The company maintained its full year earnings per share outlook. The company still projects reported earnings per share from continuing operations for the fiscal year 2012 to be between $5.33 and $5.38. Analysts polled by Thomson Reuters expect the company to report earnings of $5.38 per share for fiscal 2012. Analysts' estimates typically exclude special items.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
An administrative law judge has ruled that Minnesota regulators should approve Enbridge Inc.'s proposal to replace its aging Line 3 crude oil pipeline only if the company follows the existing route and not its preferred route. Enbridge has applied to replace its Line 3 pipeline from Alberta with new pipe along its existing route. In Minnesota, the planned route deviates from the existing route. CLICK HERE to see America's 10 Best-Selling Drugs Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV... Most Americans have access to health care, though costs and services vary from state to state. However, higher costs do not necessarily translate into better results. The U.S. continues to be outperformed by other wealthy nations on several measures like life expectancy, disease burden and health...
Follow RTT